| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5594516 | American Heart Journal | 2017 | 31 Pages |
Abstract
In ACS patients, rates of MACE for high-dose and low-dose β-blocker doses are similar. These findings question the importance of achieving a high dose of β-blocker in ACS patients and highlight the need for further investigation of this clinical question.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jason E. MD, Stacey PhD, Raymond O. MS, Tami BS, Joseph Brent MD, Jeffrey J. MD, Jeffrey L. MD,